Evidence map›Paper›PMID 29643954›Full record

ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2018

Cost-effectiveness of benign Wirsung duct strictures treatment in chronic pancreatitis.

Dariusz Łaski, Stanisław Hać, Iwona Marek, Jarosław Kobiela, Justyna Kostro, Krystian Adrych, Zbigniew Śledziński

Abstract read
In one paragraph

Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dariusz ŁaskiDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland.
Stanisław HaćDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland.
Iwona MarekDepartment of Gastroenterology and Hepatology, Medical University of Gdansk, Gdansk, Poland.
Jarosław KobielaDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland.
Justyna KostroDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland.
Krystian AdrychDepartment of Gastroenterology and Hepatology, Medical University of Gdansk, Gdansk, Poland.
Zbigniew ŚledzińskiDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic pancreatitis (CP) is an important problem for modern medicine, the healthcare system (Poland - NFZ) and the national insurance system (Poland - ZUS). The chronic nature of the disease, the lack of targeted treatment and the low mortality rate lead to an accumulation of patients who demand expensive treatment, both conservative and invasive. Rising costs in health care are forcing the need for a more cost-effective method of treatment.

aimThe primary aim of this study was to perform a retrospective calculation of costs in both surgical and endoscopic treatment, hospital stay, healthcare, and public insurance of patients suffering from chronic pancreatitis. Parallel quality of life analysis was performed. It was possible to develop a cost-effective therapeutic algorithm for patients with an uncomplicated stricture of Wirsung's duct within the Polish health care system.

resultsIn Poland, the hospital costs of endoscopic treatment of patients with chronic pancreatitis were higher than those of the surgical treatment group despite both resulting in a similar life quality.

conclusionsFrom a cost-effectiveness perspective, it was shown that surgical intervention is a more cost-effective therapy than endotherapy. Furthermore, patients with benign stricture of the main pancreatic duct in chronic pancreatitis should not be treated with endotherapy for longer than 12 months.

Indexed as

chronic pancreatitiscost-effectivenessendotherapysurgical drainage proceduresWirsung duct stricture

Identifiers

PMID29643954
PMCPMC5890842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.